Holen Sie sich die Stockscreener-App
535.00
1.17%
-6.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$541.34
Offen:
$542
24-Stunden-Volumen:
3.05M
Relative Volume:
1.53
Marktkapitalisierung:
$189.66B
Einnahmen:
$9.61B
Nettoeinkommen (Verlust:
$2.77B
KGV:
70.81
EPS:
7.555
Netto-Cashflow:
$2.27B
1W Leistung:
-8.74%
1M Leistung:
-3.53%
6M Leistung:
+4.36%
1J Leistung:
-8.40%
1-Tages-Spanne:
$532.63
$543.00
1-Wochen-Bereich:
$528.00
$582.19
52-Wochen-Spanne:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
ISRG (Intuitive Surgical, NASDAQ) down 2.46% intraday 16 Jan 2026: procedure growth guide vs AI growth outlook - Meyka
Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings - TechStock²
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - TradingView — Track All Markets
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder (NASDAQ:ISRG) - Seeking Alpha
Intuitive says general surgery, acute care fuel US robot momentum - MedTech Dive
Intuitive Surgical Advances Phase 3 Imaging Drug to Cut Ureter Injuries in Robotic Colorectal Surgery - TipRanks
Dedicated Surgeon Dr. Sharona Ross Recently Featured on Close Up Radio - The National Law Review
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet - Finviz
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Bernstein reiterates Outperform rating on Intuitive Surgical stock at $740 By Investing.com - Investing.com UK
Wilmington Savings Fund Society FSB Has $246.16 Million Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical, Inc. $ISRG Holdings Boosted by PGGM Investments - MarketBeat
The Zacks Analyst Blog Highlights American Express, Intuitive Surgical, Booking Holdings, Daily Journal and Star Group - Nasdaq
Nordea Investment Management AB Has $21.27 Million Position in Intuitive Surgical, Inc. $ISRG - MarketBeat
Davis Rea LTD. Buys New Shares in Intuitive Surgical, Inc. $ISRG - MarketBeat
Campbell & CO Investment Adviser LLC Raises Holdings in Intuitive Surgical, Inc. $ISRG - MarketBeat
Grande Ronde Hospital Foundation Raises Funds for da Vinci 5 Surgical System - La Grande Observer
Pay Less, Gain More: PODD Tops Intuitive Surgical Stock - Trefis
Activity Recap: Can TIMB disrupt its industryTrend Reversal & Weekly High Return Stock Opportunities - baoquankhu1.vn
Earnings Preview: Intuitive Surgical (ISRG) looks poised for a strong Q4 - AlphaStreet
The Truth About Intuitive Surgical Stock: Is This Robot Surgeon Still Worth Your Money? - AD HOC NEWS
Top Stock Reports for American Express, Intuitive Surgical & Booking - Yahoo Finance
Intuitive Surgical (ISRG) Is Down 7.7% After Tempered 2026 Procedure Outlook Despite Strong 2025 GuidanceHas The Bull Case Changed? - simplywall.st
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG - TechStock²
Intuitive Surgical’s IS-001 Phase 3 Update: What Investors Should Know About This Imaging-Driven Safety Play - TipRanks
Intuitive Surgical stock beats Q4 expectations as UBS maintains Neutral rating - Investing.com
Intuitive Surgical expands platforms despite market headwind - Medical Device Network
JPM26: Intuitive’s stock falls despite positive FY25 financials - Medical Device Network
Intuitive Surgical Sets Softer 2026 Outlook - GuruFocus
California-based Intuitive expects 19% revenue increase in Q4 2025 - Medical Buyer
TD Private Client Wealth LLC Sells 2,412 Shares of Intuitive Surgical, Inc. $ISRG - MarketBeat
Intuitive Surgical (NASDAQ:ISRG) Shares Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Intuitive Surgical (ISRG) stock drops after 2026 da Vinci outlook flags slower growth - TechStock²
Intuitive says daVinci systems ‘exceeded expectations,’ it wants more - MassDevice
Why This Robotics Giant Crumbled Despite Its Quarterly Beat - Investor's Business Daily
Intuitive Surgical slips, Airbnb hires Meta's former GenAI chief - Yahoo Finance
Intuitive Surgical: DV5 Adoption, Innovation Pipeline, and Robust Growth Outlook Support Premium-Valued Buy Rating - TipRanks
Intuitive Surgical (ISRG) Shares Dip on 2026 Growth Forecast - GuruFocus
ISRG: 2025 saw record growth and innovation, with 2026 set for global expansion and digital advances - TradingView — Track All Markets
Intuitive Surgical Falls as Rivalry Slows Down Flagship Robot - Bloomberg.com
Intuitive Surgical (NASDAQ:ISRG) Shares Gap DownWhat's Next? - MarketBeat
Why Intuitive Surgical Stock Is Falling Today - GuruFocus
Intuitive Surgical Updates Q4 Revenue Guidance Amid Growth Concerns - GuruFocus
Why Intuitive Surgical Stock Dropped Today - Yahoo Finance
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 - Yahoo Finance
Intuitive Reports Strong Preliminary Q4 And Full-Year 2025 Growth Ahead - Nasdaq
Why Intuitive Surgical Stock Dropped Today - The Motley Fool
Intuitive Surgical (ISRG) Shares Dip Despite Strong Revenue Grow - GuruFocus
Intuitive Surgical, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ended December 31, 2025 - marketscreener.com
Intuitive reports 19% revenue growth in Q4 2025, procedure surge By Investing.com - Investing.com India
ISRG: Strong Growth in Surgical Procedures for Q4 2025 - GuruFocus
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
3.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):